Literature DB >> 19345264

Human transplant acceptance-inducing cells suppress mitogen-stimulated T cell proliferation.

Paloma Riquelme1, Felix Gövert, Edward K Geissler, Fred Fändrich, James A Hutchinson.   

Abstract

The Transplant Acceptance-inducing Cell (TAIC) is a form of immunoregulatory macrophage which appears to be capable of establishing a state of alloantigen-specific partial tolerance of solid organ transplants in renal transplant recipients. This report establishes that human TAICs do not elicit a proliferative response from co-cultured allogeneic T cells. More significantly, it has been shown that TAICs are able to suppress proliferation of allogeneic CD4(+) and CD8(+) T cells after mitogenic stimulation. This suppressive activity can be attributed to the deletion of activated T cells by TAICs and to the secretion of a soluble inhibitor of T cell proliferation. It is further shown that the acquisition of T cell-suppressive properties by human TAICs depends upon an unidentified component of human serum.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345264     DOI: 10.1016/j.trim.2009.03.004

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  3 in total

Review 1.  Tolerance in clinical transplantation: progress, challenge or just a dream?

Authors:  Fred Fändrich
Journal:  Langenbecks Arch Surg       Date:  2011-03-17       Impact factor: 3.445

2.  IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients.

Authors:  Paloma Riquelme; Stefan Tomiuk; Anja Kammler; Fred Fändrich; Hans J Schlitt; Edward K Geissler; James A Hutchinson
Journal:  Mol Ther       Date:  2012-08-28       Impact factor: 11.454

3.  Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs.

Authors:  Paloma Riquelme; Edward K Geissler; James A Hutchinson
Journal:  Transplant Res       Date:  2012-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.